logo
I lost 18st without fat jabs – I didn't cheat my way to a new body by secretly using Ozempic, I put the effort in

I lost 18st without fat jabs – I didn't cheat my way to a new body by secretly using Ozempic, I put the effort in

Scottish Sun2 days ago
Kate Evans, 40, a full-time mum from Buckinghamshire, weighed 29st at her heaviest & is frustrated people think she resorted to fat jabs. Here's her secret...
NO WEIGH I lost 18st without fat jabs – I didn't cheat my way to a new body by secretly using Ozempic, I put the effort in
OPENING my 10th can of cola of the day and gorging on a Chinese takeaway, I felt utterly miserable.
Weighing 29st and a size 32, I was practically housebound and struggling to care for my children. It was a conversation with my husband in early 2023 that would shock me into finally losing weight, after years of it spiralling out of control.
5
At 10st 13lb, Kate's happier and healthier after losing 18st without using weight loss injections
5
Kate with husband Dan at her heaviest weight of 29st
Today, I'm more than 18st lighter, but to my frustration, there are people who don't believe I lost the weight through diet and exercise.
They accuse me of secretly using fat jabs and say I cheated my way to a new body.
When my husband Dan told me that day that he was scared I was going to die, I knew his fears were justified. At 38, I was pre-diabetic and could barely walk, with aching joints and breathlessness. I agreed to join a slimming club, but had no idea how I'd lose the excess weight.
All my life, I've been big. At 10, I weighed 9st, the weight of an adult woman, because I had a big appetite.
BIG APPETITE
As a teenager, when I had more independence and money to spend, I'd buy crisps, chocolate and fizzy drinks. I did try a few times to lose weight in my 20s, but always gave up and put it back on, and more.
When I met Dan online in 2013, after having my first child in a previous relationship, I was a size 24. He didn't care, though, and saw past my weight. He loved me as I was, and we got married in 2016.
I treated food like an emotional crutch. No matter how I was feeling, I turned to it. I look back with horror at what I'd consume daily – litres of fizzy drink, greasy takeaways, piles of buttered toast and chocolate.
By the time Dan had that emotional conversation with me, I was only leaving the house once a week to go to the supermarket, and I slept downstairs because getting up to our bedroom was too hard for me.
'No shortcuts exist' I'm an Irish teen who lost almost 60 pounds in 16 weeks following a routine that works wonders
He had to take on more than his share, and I could never take the kids to the park or on a day trip. Had Dan not confided his fears in me, I'm not sure if I'd have ever given myself that push to lose weight.
Stepping on to the scales at my first slimming club meeting in February 2023, I felt mortified. At 29st 4.5lb, I was by far the biggest person there. But for Dan and my children's sake, I knew I needed to try.
So, using the club's plan as a starting point, I began learning about nutrition. I started having fruit and yoghurt for breakfast, a wrap with salad for lunch, and chicken with veg for dinner. I stopped having takeaways and gradually weaned myself off sugary drinks.
Attending a weekly meeting and being weighed kept me accountable, and as I started to see the number on the scales go down, I felt motivated to keep going. I began to introduce walking, too.
At first, even short distances left me with sore joints and out of breath, but I persevered and it became more enjoyable.
5
Kate ended up practically housebound and struggling to care for her children due to her weight
5
Kate lost the weight to be a better mum
5
Kate's husband Dan was scared she was going to die because of the excess weight
Dan was so supportive and relieved I was taking care of myself. By April 2024, I'd lost 17st. I decided to keep going and now weigh 10st 13lb. I don't plan to lose any more, but still attend my weekly club meetings.
It's surreal when I walk into a clothes shop and can pick out size-12 dresses. People I haven't seen in a while have walked past, not recognising me, and there was even a rumour in our area Dan was having an affair, because he was spotted with another woman. But that was me!
What frustrates me is, after all the effort I've put in, I've been accused of secretly using weight-loss jabs. I've seen it happen online to celebrities, such as TV presenter Alison Hammond, who's lost 11st without jabs, too.
Personally, I think it's cheating to use them to lose weight. I put the pounds on and it was up to me to lose them, not rely on pharmaceuticals.
When I look back at old photos, I don't recognise that unhealthy, unhappy woman.
I've saved my life and am the active, happy wife and mum I always dreamed of being. And I did it all by myself.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New ‘crucial' fat jabs guidance issued for the NHS – are you affected?
New ‘crucial' fat jabs guidance issued for the NHS – are you affected?

Scottish Sun

time5 hours ago

  • Scottish Sun

New ‘crucial' fat jabs guidance issued for the NHS – are you affected?

Hundreds of thousands of Brits take the injections JABS UPDATE New 'crucial' fat jabs guidance issued for the NHS – are you affected? Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) FAT jabs are not a 'quick fix' and patients must be followed up for at least a year to keep the weight off, the NHS watchdog has warned. The National Institute for Health and Care Excellence (Nice) told clinics to offer more follow-up appointments and aftercare. Sign up for Scottish Sun newsletter Sign up 1 2RD5P46 photo of Mounjaro Weight Loss Pen Credit: Alamy More than 1.5million Brits are thought to be taking weight loss injections such as Wegovy and Mounjaro. Most are on private prescriptions where many do not receive help with diet and exercise alongside the medication. Studies suggest people start re-gaining weight within two months of stopping the jabs, and often put it all back on within two years. Professor Jonathan Benger, chief medical officer at Nice, said: 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme. 'The transition period after treatment is crucial. 'People need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care.' Check-ups to prevent weight regain The standard issued to NHS clinics tells them how to look after patients taking weight loss injections. They must get action plans for staying healthy at home and at work, have regular check-ins and have community support available. Dr Rebecca Payne, head of standards at Nice, said: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines can help prevent weight regain.' Sun Health Explainer: Fat jabs Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.

Wegovy maker Novo hit with investor class action over revenue forecast cut
Wegovy maker Novo hit with investor class action over revenue forecast cut

Reuters

time11 hours ago

  • Reuters

Wegovy maker Novo hit with investor class action over revenue forecast cut

Aug 4 (Reuters) - Novo Nordisk ( opens new tab, maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish pharmaceutical giant misled them with optimistic growth forecasts and minimized competition risks in the obesity market. The proposed class action lawsuit, opens new tab was filed on Friday in the federal court in New Jersey following a sharp decline in the company's stock price. Investors knocked $70 billion off Novo Nordisk's market value on a single trading day last week. Novo last week in a statement said it was lowering its 2025 sales and operating profit outlook due to lower growth expectations in the second half in the United States for Wegovy in the obesity market and the drugmaker's Ozempic in the diabetes market. Novo said its updated sales outlook for Wegovy stemmed from the 'persistent' use of compounded versions of the drug, competition and what it described as slower-than-expected market expansion. A representative from Novo and an attorney for the plaintiff did not immediately respond to requests for comment on Monday about the investor lawsuit. The lawsuit was filed on behalf of potentially thousands of investors who purchased Novo's stock between May 7, 2025 and July 28. The tight supply of Wegovy in the United States in 2022 prompted U.S. regulators to temporarily allow the sale of cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Novo in June said it was ending a partnership with telehealth company Hims & Hers that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum in a response accused Novo management of misleading the public and making anticompetitive demands. The case is Eric Barta v. Novo Nordisk et al, U.S. District Court, District of New Jersey, No. 2:25-cv-14045. For plaintiff: Adam Apton of Levi & Korsinsky For defendants: No appearances yet Read more: Novo Nordisk shares dip further as Wegovy gains nearly erased Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership Wegovy maker Novo faces fee demand after losing copycat drug lawsuit Ozempic copies restricted after US judge denies injunction

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store